|
IOVA Iovance Biotherapeutics Inc 1425205 |
| Balance Sheet |
|
Current Assets
|
$466,502,000.00 |
|
Assets
|
$925,665,000.00 |
|
Current Liabilities
|
$129,420,000.00 |
|
Liabilities
|
$203,911,000.00 |
|
Equity
|
$721,754,000.00 |
|
Shares Out
|
438106537.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-72,074,000.00 |
|
Investing Cash Flow
|
$11,394,000.00 |
| Market Analysis |
Market Cap
|
$2,054,719,658.53 |
|
Price
|
$4.19 |
|
BVPS
|
1.65 |
|
PB
|
2.84 |
|
EPS
|
-0.19 |
|
PS
|
6.61 |
|
FCF
|
$-78,682,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
-0.18 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.19 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.33 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IOVA documents filed with the SEC.
IOVA Filings
Clear
